Skip to main content


Fig. 2 | Journal of Intensive Care

Fig. 2

From: Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

Fig. 2

Forest plot of mortality in randomized trials of patients with ARDS, by glucocorticoid molecule. Hospital mortality for patients (n = 766) randomized before day 14 of ARDS onset in nine randomized trials investigating prolonged glucocorticoid treatment in ARDS. Comparison between randomized trials which investigated methylprednisolone (n = 272) vs. hydrocortisone (n = 494) treatment. M–H Mantel–Haenszel statistics, df degrees of freedom

Back to article page